21829-25-4

Nifedipine (Procardia) is a dihydropyridine calcium channel blocking agent. Nifedipine inhibits the transmembrane influx of extracellular calcium ions into myocardial and vascular smooth muscle cells, causing dilatation of the main coronary and systemic arteries and decreasing myocardial contractility. This agent also inhibits the drug efflux pump P-glycoprotein which is overexpressed in some multi-drug resistant tumors and may improve the efficacy of some antineoplastic agents.

Nifedipine-D6 is deuterium labeled nifedipine (T1146) which is a potent blocker of calcium channel.

Nifedipine-D4 is the deuterated form of Nifedipine. Nifedipine (T1146) (BAY-a-1040) is a potent calcium channel blocker widely used in studies related to myocardial dysfunction.

Nifedipine-D6 (Standard) is a reference standard of Nifedipine-D6 intended for quantitative analysis, quality control, and related biochemical research applications.

Nifedipine-13C8 (Standard) is a reference standard of Nifedipine-13C8 intended for quantitative analysis, quality control, and related biochemical research applications. Nifedipine-13C8 is a deuterium-labeled form of Nifedipine. Nifedipine (BAY-a-1040) acts as an effective calcium channel blocker, frequently utilized in studies related to myocardial dysfunction.

Nifedipine-13C8 is a deuterium-labeled form of Nifedipine. Nifedipine (T1146) (BAY-a-1040) acts as an effective calcium channel blocker, frequently utilized in studies related to myocardial dysfunction.

Nifedipine HCl is a potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.